Report Highlights
The global sterile filtration market should reach $5.3 billion by 2027 from $3.0 billion in 2022 at a compound annual growth rate (CAGR) of 12.0% for the forecast period of 2022 to 2027.
Report Includes
- 32 tables
- An up-to-date overview of the global market for sterile filtration for life sciences application
- Analyses of the global market trends, with historic sales data from 2020 and 2021, estimates for 2022, and projections of compound annual growth rates (CAGRs) through 2027
- Highlights of the upcoming market potential for sterile filtration in life sciences industry, and areas of focus to forecast this market into various segments and subsegments
- Evaluation and forecast the sterile filtration for life science application market size, projected growth trends, and corresponding market share analysis by pore size, material and geographic region
- Discussion of new technological developments in this innovation driven market, current and emerging applications, regulatory concerns, and other major factors hampering the growth of the sterile filtration market
- Detailed analysis on the strength, weakness and opportunities of the prominent players operating in the global sterile filtration market
- In-depth information on increasing investments on R&D activities, key technology issues, industry specific challenges, major types of end-user markets and COVID-19 implications on the progress of this market
- A relevant patent analysis for innovations in sterile filtration
- Descriptive company profiles of the leading global players, including 3M, Danaher Corp., Merck KGaA, Porvair PLC and Thermo Fisher Scientific Inc.
Report Scope
This report estimates the future market potential for sterile filtration for life science applications. It provides a detailed analysis of the competitive environment, regulatory scenario, drivers, restraints, opportunities, and trends in the market. The report also covers market projections Through 2027 and key market players.
This report discusses the global market for sterile filtration used in life science applications, including depth filters, microfiltration membranes and air filters. The report also analyzes various materials of filters being used n sterilization filtration.
In this report, the market is segmented by region into North America, Europe, Asia-Pacific, and the rest of the world (including Latin America, the Middle East and Africa). Countries analyzed include the U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India). Estimated values are based on product manufacturers’ total revenues. Projected and forecasted revenue values are in constant U.S. dollars that have not been adjusted for inflation.
Report Synopsis
Report Metrics | Details | ||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Base year considered | 2021 | ||||||||||||||||
Forecast period considered | 2022-2027 | ||||||||||||||||
Base year market size | $2.7 billion | ||||||||||||||||
Market size forecast | $5.3 billion | ||||||||||||||||
Growth rate | CAGR of 12.0% for the forecast period of 2022-2027 | ||||||||||||||||
Units considered | $ Millions | ||||||||||||||||
Segments covered | By pore size, material, and Region | ||||||||||||||||
Regions covered | North America, Europe, Asia-Pacific, and the Rest of the World | ||||||||||||||||
Countries covered | U.S., Canada, Germany, the U.K., France, Spain, Italy, Japan, China and India | ||||||||||||||||
Key Market Drivers |
|
||||||||||||||||
Companies studied |
|
Analyst Credentials
BCC Research Team possesses expertise and experience in life and physical science domains. They specialize in offering valuable business insights, including industry analysis, competitor intelligence, strategic and financial analysis, and opportunity assessment. The team has in-depth knowledge of various sectors, including healthcare, biotechnology, pharmaceuticals, IT, automation, advanced materials, and energy. They are proficient in qualitative and quantitative market intelligence providing clients with actionable insights. With a vast understanding of the competitive landscape, the team can support clients in making data-driven decisions to help them achieve a competitive edge in their respective markets.
- Alzheimer's Disease Therapeutics and Diagnostics: Global Markets (PHM062E)
- Impact Modifiers: Global Markets (AVM252A)
- Adhesives and Adhesive-Applying Equipment: Technologies and Global Markets (CHM073E)
- Bioprocess Optimization and Digital Bio-manufacturing: Global Markets (BIO170B)
- Metal-organic Frameworks: Global Markets (AVM200B)
Related Reports
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global Markets and Technologies for Nanofiltration
The global market for nanofiltration is expected to grow from $1.5 billion in 2024 and is projected to reach $3.4 billion by the end of 2029, at a compound annual growth rate (CAGR) of 17.6% during the forecast period of 2024 to 2029.
Pharmaceutical Filtration: Global Markets
The global market for pharmaceutical filtration was valued at $10.4 billion in 2023. The market is estimated to grow from $11.4 billion in 2024 to $18.1 billion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 to 2029.
Global Market for Membrane Microfiltration
The global microfiltration membranes market reached $3.9 billion in 2022 and should reach $6 billion by 2027, with a compound annual growth rate (CAGR) of 8.8% during the forecast period of 2022-2027.
Recent Reports
Bioprocess Optimization and Digital Bio-manufacturing: Global Markets
The global market for bioprocess optimization and digital biomanufacturing is expected to grow from $24.3 billion in 2024 and is projected to reach $39.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 10.2% during the forecast period of 2024 to 2029.
Global DNA Sequencing: Research, Applied and Clinical Markets
The global market for DNA sequencing is expected to grow from $14.8 billion in 2024 and is projected to reach $34.8 billion by the end of 2029, at a compound annual growth rate (CAGR) of 18.6% during the forecast period of 2024 to 2029.
Artificial Intelligence (AI) in Cancer
The global market for artificial intelligence (AI) in cancer is estimated to increase from $2.2 billion in 2024 to reach $6.3 billion by 2029, at a compound annual growth rate (CAGR) of 23.1% from 2024 through 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Top Trending Reports
Single-use Technologies for Biopharmaceuticals: Global Markets
The global market for single-use technologies for biopharmaceuticals is expected to grow from $6.5 billion in 2024 and is projected to reach $11.2 billion by the end of 2029, at a compound annual growth rate (CAGR) of 11.6% during the forecast period of 2024 to 2029.
Cell and Gene Therapy Tools, and Reagents: Global Markets
The global market for Cell and Gene Therapy (CGT) Tools and Reagents is estimated to increase from $10.0 billion in 2024 to reach $16.7 billion by 2029, at a compound annual growth rate (CAGR) of 10.8% from 2024 through 2029.
Medical Devices Industry: Competitive Landscape
The global market for medical devices is estimated to increase from 810.4 billion in 2024 to reach $1.3 trillion by 2029, at a compound annual growth rate (CAGR) of 9.8% from 2024 through 2029.
Global Market Opportunities and Competitive Landscape for CDMO
The global CDMO market was valued at $128.0 billion in 2023. This market is expected to grow from $136.6 billion in 2024 to $191.6 billion by the end of 2029, at a compound annual growth rate (CAGR) of 7.0% from 2024 to 2029.
Chronic Disease Management: Therapeutics, Device Technologies and Global Markets
The global market for chronic disease management therapeutics and device technologies was valued at $675.0 billion in 2023. It is projected to grow from $726.3 billion in 2024 to $1.1 trillion by 2029, at a compound annual growth rate (CAGR) of 8.1% from 2024 through 2029.
Become A Member
BCC Research offers a comprehensive library of reports, granting members unlimited access to data, insights, and market intelligence for informed business decisions, while actively supporting members in their evolving journeys and prioritizing high-quality, relevant topics based on continuous engagement with the research community.
Find Out MoreCustom Consulting
BCC Research emphasizes the importance of organizations leveraging highly customized market insights aligned with specific strategic business objectives through direct engagement with primary sources and proprietary forecasting models for profitable decision-making in maximizing growth opportunities and minimizing risks.
Customize NowScorecard
The Venture Scorecard provides commercialization offices and decision makers with expert analysis, offering strategic insights crucial for aligning objectives with market realities at various stages of commercializing new products or evaluating investment opportunities, from opportunity assessment to growth planning.
Find Out MoreInnovation Spotlight
Our industry experts offer strategic guidance to maximize the market potential of commercialized products, patents, and IP by providing insights into market trends, competitive dynamics, and effective positioning, using the Innovation Spotlight service for enhanced exposure to thought leaders and the wider community.
Find Out More